SIRT1 and fatty liver disease: Concerning SIRT1, a trial conducted in obese patients with MASLD showed a lower plasma SIRT1 levels in patients with either moderate or severe liver steatosis compared to the mild steatosis group, and that plasma SIRT1 negatively correlated with liver steatosis [54].